Changes in Outcome of Patients with Advanced Non-Clear Cell Renal Cell Carcinoma from the Tyrosine Kinase Inhibitor Era to the Immuno-Oncology Era
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY(2024)
Key words
Nivolumab,Ipilimumab,Papillary renal cell carcinoma,Cabozantinib,Lenvatinib,Pembrolizumab,Immune checkpoint inhibitor,Axitinib,Avelumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined